Cytokines, Toxoplasma and intracellular parasitism (Q35732488)

9 August 2017

1 reference

title

Cytokines, Toxoplasma and intracellular parasitism (English)

1 reference

9 August 2017

Beaman MH

1

1 reference

9 August 2017

Wong SY

series ordinal

2

1 reference

9 August 2017

Remington JS

series ordinal

3

1 reference

9 August 2017

publication date

1 June 1992

1 reference

9 August 2017

published in

Immunological Reviews

1 reference

9 August 2017

volume

127

1 reference

9 August 2017

page(s)

97-117

1 reference

Effect of normal and activated human macrophages on Toxoplasma gondii

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01410.X

Synergistic activity of azithromycin and gamma interferon in murine toxoplasmosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01410.X

Interferon decreases the growth inhibition of Mycobacterium avium-intracellulare complex by fresh human monocytes but not by culture-derived macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01410.X

Inhibition of multiplication of Toxoplasma gondii by human monocytes exposed to T-lymphocyte products

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01410.X

Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01410.X

In vivo synergism of roxithromycin (RU 965) and interferon against Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01410.X

Activity of gamma interferon in combination with pyrimethamine or clindamycin in treatment of murine toxoplasmosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01410.X

Assessment in vitro of immunity against Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01410.X

AIDS commentary. Toxoplasmic encephalitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01410.X

Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01410.X

Activation of human macrophages. Comparison of other cytokines with interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01410.X

Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01410.X

Strain differences of interferon-generating capacity and resistance in toxoplasma-infected mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01410.X

Differences in virulence and development of encephalitis during chronic infection vary with the strain of Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01410.X

Tumor necrosis factor plays a protective role in experimental murine cutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01410.X

Failure to trigger the oxidative metabolic burst by normal macrophages: possible mechanism for survival of intracellular pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01410.X

Deficiency of immune interferon production by leukocytes of normal newborns

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01410.X

Human tumor necrosis factor increases the resistance against Listeria infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01410.X

Production of gamma interferon by cultured human lymphocytes stimulated with a purified membrane protein (P30) from Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01410.X

Effect of murine interferon gamma on murine toxoplasmosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01410.X

Hemopoietic colony-stimulating factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01410.X

Effects of cyclosporin A on susceptibility and interferon-generating capacity in mice infected with Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01410.X

Production and Properties of Immune Interferon from Spleen Cell Cultures ofToxoplasma-Infected Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01410.X

An In Vitro Study on Lymphocyte-Mediated Immunity in Mice Experimentally Infected with Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01410.X

Association of symptomatic human infection with Toxoplasma gondii with imbalance of monocytes and antigen-specific T cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01410.X

High risk of developing toxoplasmic encephalitis in AIDS patients seropositive to Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-065X.1992.TB01410.X

10.1111/J.1600-065X.1992.TB01410.X

21 January 2018

Identifiers

DOI

1 reference

9 August 2017

1 reference